CRA国际 CRAI 深 沪
等待开盘 02-10 09:30:00 美东时间
177.77
-7.190
-3.89%
华盛通- 最 高184.89
- 今 开184.08
- 成交量 11.27万股
- 最 低 175.65
- 昨 收 184.96
- 总市值 11.67亿
- 52周最高 227.29
- 市盈率 静 26.39
- 换手率 1.72%
- 52周最低 151.02
- 委 比 -43.59%
- 总股本 656.23万
- 历史最高 227.29
- 量 比 0.81
- 振 幅 5.00%
- 历史最低 2.52
- 每 手 1
- 风险率 13.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Barrington Research Maintains Outperform on CRA Intl, Raises Price Target to $245
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and raises the price target from $239 to $245.
01-05 23:22
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
Barrington Research Maintains Outperform on CRA Intl, Maintains $239 Price Target
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and maintains $239 price target.
2025-11-25 01:34
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
CRA Intl Raises FY2025 Sales Guidance from $730.000M-$745.000M to $740.000M-$748.000M vs $734.647M Est
CRA Intl (NASDAQ:CRAI) raises FY2025 sales outlook from $730.000 million-$745.000 million to $740.000 million-$748.000 million vs $734.647 million estimate.
2025-10-30 20:07
Charles River Associates Increases Its Quarterly Cash Dividend From $0.49 To $0.57 Per Common Share
Quarterly DividendOn October 30, 2025, CRA announced that it increased its quarterly cash dividend by 16% from $0.49 to $0.57 per common share. The dividend will be payable on December 12, 2025 to shareholders of record
2025-10-30 20:07
CRA Intl Q3 Adj. EPS $2.06 Beats $1.80 Estimate, Sales $185.891M Beat $179.423M Estimate
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.06 per share which beat the analyst consensus estimate of $1.80 by 14.44 percent. This is a 16.38 percent increase over earnings of $1.77 per share from the same
2025-10-30 20:06
CRA International Announces Quarterly Dividend and Record Revenue
Cra International ( ($CRAI) ) just unveiled an update. On July 31, 2025, Charle...
2025-07-31 20:27
CRA Intl Raises FY2025 Sales Guidance from $715.000M-$735.000M to $730.000M-$745.000M vs $724.289M Est
CRA Intl (NASDAQ:CRAI) raises FY2025 sales outlook from $715.000 million-$735.000 million to $730.000 million-$745.000 million vs $724.289 million estimate.
2025-07-31 20:08
